jb chemicals: JB Chemicals gets USFDA nod to market generic medication

JB Chemical compounds & Prescribed drugs on Wednesday mentioned via its trade submitting that it has obtained approval from the US well being regulator to market a generic product, used to deal with temper issues, within the American market.

The corporate has obtained approval from the US Meals and Drug Administration to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, JB Chemical compounds & Prescribed drugs mentioned in a regulatory submitting.

The corporate’s product is the generic model of Pfizer’s Sinequan capsules that are indicated for the remedy of tension, melancholy, and different goal signs of psychoneurosis.

The drug will probably be manufactured on the firm’s formulation manufacturing facility in Panoli, Gujarat, the drug maker famous.
As per IQVIA MAT knowledge, Doxepin Hydrochloride capsules had an estimated annual gross sales of USD 23.90 million within the US.

Shares of JB Chemical compounds have been buying and selling 3.86 per cent up at Rs 2,754.90 apiece on the BSE.